Trial Profile
A Study to Assess the Pharmacodynamic Equivalence of Two Orlistat Dosage Forms
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 07 May 2018 New trial record